准备用多糖衍生物修饰的尺寸控制型脂质体,用于pH响应药物输送应用
Shin Yanagihara1, Yukiya Kitayama1,2, Eiji Yuba1,2
1Department of Applied Chemistry, Graduate School of Engineering, Osaka Prefecture University, 1-1 Gakuen-cho, Naka-ku, Sakai 599-8531, Osaka, Japan.
Life (Basel, Switzerland)
|November 25, 2023
概括
脂质体大小会影响药物释放. 较小的脂质体显示出增强的pH响应释放,但高胆固醇含量会降低响应能力,这对于药物输送应用至关重要.
科学领域:
- 生物技术是生物技术.
- 材料科学 材料科学 材料科学
- 制药科学 制药科学
背景情况:
- 脂质体颗粒大小对于控制药物释放至关重要,原因是双层曲率和脂质包装的变化.
- 之前的研究使用了100-200纳米的脂质体,因此大小对pH响应性质的影响尚不清楚.
研究的目的:
- 为了研究脂质体大小对pH响应内容释放的影响.
- 探索胆固醇在脂质体稳定性和响应性中的作用.
主要方法:
- 使用通过不同孔径的聚碳酸膜的挤出来控制脂质体大小.
- 胆固醇被纳入脂质体脂质成分中,以评估其对尺寸稳定性的影响.
- 响应pH的内容释放在中性和弱酸性pH条件下测量.
主要成果:
- 脂质体大小与聚碳酸膜孔径大小直接相关.
- 较小的脂质体与较大的脂质体相比,显示了显著更高的pH响应的内容释放.
- 含有50mol%胆固醇的脂质体表现出抑制的内容释放,即使在酸性条件下.
结论:
- 脂质体大小和胆固醇含量是稳定脂质体在生理pH下发展的关键因素.
- 对脂质体大小和胆固醇水平的精确控制对于优化响应pH的药物递送系统至关重要.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Influencing Factors
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


